首页|牛肺表面活性剂对新生儿急性呼吸窘迫综合征患者的临床疗效

牛肺表面活性剂对新生儿急性呼吸窘迫综合征患者的临床疗效

Clinical research of Pulmonary surfactant on neonatal with acute respiratory distress syndrome

扫码查看
目的 探讨牛肺表面活性剂对新生儿急性呼吸窘迫综合征患者临床疗效.方法 收集宁波市第四医院就诊的98例新生儿呼吸窘迫综合征患者,随机分为试验组和对照组,每组49例.均给予保暖、抗感染、保持内环境稳定、预防出血等常规治疗.对照组患者给予机械持续正压通气,试验组在对照组基础上给予牛肺表面活性剂100mg/kg,配制成浓度为50mg/mL,摇匀后经气管插管,分别取平卧、侧卧位(左、右)、半卧位等4个体位缓慢注入,使其在患者肺内分布均匀,用药1~2次.观察并比较2组患者治疗前后呼吸频率(RR)、酸碱度(pH)、氧分压(PaO2)、二氧化碳分压(PaCO2)水平以及并发症发生率、患者临床治疗有效率水平.结果 与治疗前相比,治疗后2组患者的RR、PaCO2水平均下降,pH、PaO2水平均升高,差异具有统计学意义(P<0.05);与对照组相比,试验组患者RR、PaCO2水平较低,pH、PaO2水平较高,差异具有统计学意义(P<0.05);与对照组相比,试验组患者并发症发生率较低,临床治疗有效率较高,差异具有统计学意义(P<0.05).结论 牛肺表面活性剂能够降低新生儿急性呼吸窘迫综合征患者呼吸频率,改善患者动脉血气水平,临床疗效较好.
Objective To investigate the effect of pulmonary surfactant on neonatal with acute respiratory distress syndrome.Methods98 cases with neonatal respiratory distress syndrome inthe fourth hospital of Ningbo were randomly divided into experimental group and control group, 49 cases in each group.All patients were given warm, anti infection, and maintain the internal environment stability, prevention of bleeding and other conventional treatment.The control group were treated with mechanical CPAP, the experimental group were given pulmonary surfactant 70mg/kg, concentration is 35mg/mL.Pulmonary surfactant was injected slowly by tracheal intubation at supine, lateral(left, right) and semi recumbent position.The drug was distributed evenly in the lung of the patients who were given the drug 1-2 times.Respiratory frequency (RR), pH, oxygen partial pressure (PaO2), partial pressure of carbon dioxide (PaCO2) levels and the incidence of complications, clinical effective rate of the tthe two groups were observed and compared.ResultsCompared with pre-treatment, RR and PaCO2 levels were decreased, pH and PaO2 levels were increased after treatment in the two groups, the differences were statistically significant (P<0.05);compared with the control group, RR, PaCO2 level were lower, pH and PaO2 levels were higher in the experimental group, the differences has statistical significance (P<0.05);compared with the control group, the experimental groupwith a low incidence of complications, clinical effective rate is higher, the difference was statistically significant (P<0.05).ConclusionPulmonary surfactant can reduce the respiratory frequency in neonatal with acute respiratory distress syndrome, improve arterial blood gas levels, which get better clinical curative effect.

pulmonary surfactantneonatalacute respiratory distress syndrome

陈立春、许爱静、唐晓明

展开 >

宁波市第四医院儿科,浙江宁波315700

牛肺表面活性剂 新生儿 急性呼吸窘迫综合征

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.(5)
  • 6
  • 8